We previously demonstrated that LZTS2 binds to the PI3K subunit p85 to inhibit the activation of the PI3K/AKT signaling pathway and overcomes radioresistance in nasopharyngeal carcinoma [24]. This evidence concerns the gene LZTS2 and nasopharyngeal carcinoma.